Single-Dose Replication-Defective VSV-based Nipah Virus Vaccines Provide Protection from Lethal Challenge in Syrian Hamsters
Supporting Files
-
October 30 2013
-
File Language:
English
Details
-
Alternative Title:Antiviral Res
-
Personal Author:
-
Description:Nipah virus (NiV) continues to cause outbreaks of fatal human encephalitis due to spillover from its bat reservoir. We determined that a single dose of replication-defective vesicular stomatitis virus (VSV)-based vaccine vectors expressing either the NiV fusion (F) or attachment (G) glycoproteins protected hamsters from over 1000 times LD50 NiV challenge. This highly effective single-dose protection coupled with an enhanced safety profile makes these candidates ideal for potential use in livestock and humans.
-
Subjects:
-
Source:Antiviral Res. 101
-
Pubmed ID:24184127
-
Pubmed Central ID:PMC3874889
-
Document Type:
-
Funding:
-
Volume:101
-
Collection(s):
-
Main Document Checksum:urn:sha256:1157304ad7286e9923fed82b5d187628b5848e60465173df73b4459dfb418a58
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access